Do we need new autoantibodies in lupus?
- PMID: 20537203
- PMCID: PMC2911855
- DOI: 10.1186/ar2998
Do we need new autoantibodies in lupus?
Abstract
Systemic lupus erythematosus (SLE) is a clinically and serologically complex disease that demonstrates clinical, epidemiological and genetic differences among racial and ethnic groups. Some autoantibodies are useful for diagnosis of the illness. Others are clinically important because of associations with a particular manifestation of SLE. Antibodies to RNA helicase A (anti-RHA) comprise a newly described class of SLE autoantibodies. These antibodies have so far been found only in SLE patients and differ substantially in prevalence and nature between Mexican and white American SLE patients. Study of anti-RHA may provide insights into the origin of population differences in SLE.
Comment on
-
High prevalence of autoantibodies to RNA helicase A in Mexican patients with systemic lupus erythematosus.Arthritis Res Ther. 2010;12(1):R6. doi: 10.1186/ar2905. Epub 2010 Jan 8. Arthritis Res Ther. 2010. PMID: 20064217 Free PMC article.
References
-
- Vázquez-Del Mercado M, Palafox-Sánchez CA, Muñoz-Valle JF, Orozco-Barocio G, Oregon-Romero E, Navarro-Hernández RE, Salazar-Páramo M, Armendariz-Borunda J, Gámez-Nava JI, Gonzalez-Lopez L, Chan J, Chan EKL, Satoh M. High prevalence of autoantibodies to RNA helicase A in Mexican patients with systemic lupus erythematosus. Arthritis Res Ther. p. R6. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
